CCM
TMO icon

Compton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Compton Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,370
Closed -$1.37M – 43
2023
Q1 		$1.37M Sell
2,370
-5,145
-68% -$2.9M 2.94% 9
2022
Q4 		$4.14M Sell
7,515
-1,118
-13% -$592K 2.98% 8
2022
Q3 		$4.38M Sell
8,633
-910
-10% -$509K 2.93% 7
2022
Q2 		$5.18M Sell
9,543
-4,502
-32% -$2.48M 2.86% 6
2022
Q1 		$8.3M Sell
14,045
-370
-3% -$213K 2.32% 9
2021
Q4 		$9.62M Sell
14,415
-780
-5% -$487K 2.5% 9
2021
Q3 		$8.68M Sell
15,195
-355
-2% -$195K 2.55% 8
2021
Q2 		$7.84M Hold
15,550
– – 2.31% 8
2021
Q1 		$7.1M Buy
15,550
+150
+1% +$71.6K 2.22% 9
2020
Q4 		$7.17M Sell
15,400
-310
-2% -$145K 2.43% 7
2020
Q3 		$6.94M Sell
15,710
-100
-0.6% -$41.3K 2.66% 7
2020
Q2 		$5.73M Sell
15,810
-125
-0.8% -$41.9K 2.4% 8
2020
Q1 		$4.52M Sell
15,935
-165
-1% -$52K 2.23% 9
2019
Q4 		$5.23M Sell
16,100
-525
-3% -$159K 2.03% 7
2019
Q3 		$4.84M Sell
16,625
-50
-0.3% -$14.3K 2.03% 9
2019
Q2 		$4.9M Sell
16,675
-450
-3% -$124K 2.07% 8
2019
Q1 		$4.69M Sell
17,125
-265
-2% -$65.9K 2.04% 8
2018
Q4 		$3.89M Sell
17,390
-285
-2% -$66.9K 1.86% 10
2018
Q3 		$4.31M Buy
17,675
+160
+0.9% +$36.8K 1.7% 11
2018
Q2 		$3.63M Buy
17,515
+20
+0.1% +$4.25K 1.53% 14
2018
Q1 		$3.61M Sell
17,495
-50
-0.3% -$10.5K 1.53% 11
2017
Q4 		$3.33M Hold
17,545
– – 1.42% 19
2017
Q3 		$3.32M Sell
17,545
-487
-3% -$88.2K 1.49% 17
2017
Q2 		$3.15M Sell
18,032
-100
-0.6% -$16.8K 1.43% 17
2017
Q1 		$2.79M Sell
18,132
-15
-0.1% -$2.29K 1.37% 19
2016
Q4 		$2.56M Sell
18,147
-17,967
-50% -$2.65M 1.34% 21
2016
Q3 		$5.54M Buy
36,114
+18,147
+101% +$2.8M 1.53% 17
2016
Q2 		$2.65M Buy
17,967
+180
+1% +$26.6K 1.48% 18
2016
Q1 		$2.52M Hold
17,787
– – 1.41% 19
2015
Q4 		$2.52M Sell
17,787
-50
-0.3% -$6.67K 1.43% 20
2015
Q3 		$2.18M Sell
17,837
-200
-1% -$26.1K 0.79% 20
2015
Q2 		$2.34M Hold
18,037
– – 1.29% 19
2015
Q1 		$2.42M Sell
18,037
-405
-2% -$52.2K 1.35% 20
2014
Q4 		$2.31M Sell
18,442
-150
-0.8% -$18.2K 1.26% 23
2014
Q3 		$2.26M Sell
18,592
-720
-4% -$87.5K 1.23% 23
2014
Q2 		$2.28M Sell
19,312
-493
-2% -$58K 1.23% 24
2014
Q1 		$2.38M Sell
19,805
-50
-0.3% -$5.95K 1.37% 21
2013
Q4 		$2.21M Sell
19,855
-50
-0.3% -$4.97K 1.26% 25
2013
Q3 		$1.83M Sell
19,905
-400
-2% -$36.2K 1.12% 29
2013
Q2 		$1.72M Buy
+20,305
New +$1.69M 1.06% 29

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Compton Capital Management's TMO Position: Q2 2023 in Review

Compton Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 2,370 shares — an estimated $1.37M sold.

Compton Capital Management first reported a position in TMO in Q2 2013 and held it in 40 quarters. The position peaked at $9.62M in Q4 2021. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Compton Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Compton Capital Management sold 2,370 Thermo Fisher Scientific shares in Q2 2023, an estimated $1.37M.
  • Compton Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 40 quarters.
  • Compton Capital Management's Thermo Fisher Scientific position peaked at $9.62M in Q4 2021.
  • 2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Compton Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.